Interferon status in the normal state
Ershov, F.I.; Gotovtseva, E.P.
Voprosy Virusologii 34(1): 16-22
1989
ISSN/ISBN: 0507-4088 PMID: 2471357 Document Number: 330660
Document emailed within 1 workday
Related Documents
Günther, G.; Otto, B. 1993: Interferon. An overview of the state of basic research with special regard to interferon-gamma Arzneimittel-Forschung 43(2): 182-188Silverman, A.L.; Piquette, D.L.; Filipiak, C.L.; Neill, J.S.; Bayati, N.; Gordon, S.C. 1997: Alfa interferon treatment of hepatitis C virus RNA-positive patients with normal or near-normal alanine aminotransferase levels American Journal of Gastroenterology 92(10): 1793-1795
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Onsrud, M. 1982: Interferon therapy--current state Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(34-36): 1830-1831
Iashaeva, I.G.; Samsonov, V.A.; Malinovskaia, V.V.; Dzhumigo, P.A. 1990: Interferon status in atopic dermatitis Sovetskaia Meditsina 6: 92-94
Miller, V.S.; Zwiener, R.J.; Fielman, B.A. 1994: Interferon-associated refractory status epilepticus Pediatrics 93(3): 511-512
Dugan, W.M. 1979: Interferon: history, present status Journal of the Indiana State Medical Association 72(1): 16
Billiau, A.; De Somer, P.; De Maeyer, E. 1971: Current status and prospects for interferon Progress in Immunobiological Standardization 5: 264-266
Ogawa, M. 1983: Current status of clinical studies of interferon Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1717-1721
Marionnet, A.V.; Lizard, G.; Chignol, M.C.; Chardonnet, Y.; Schmitt, D. 1996: Differences in reactivity to cyclosporin a and interferon-gamma of normal and HPV-transformed keratinocytes Anticancer Research 16(1): 257-267
Chernushenko, E.F.; Belianovskaia, T.I.; Kuznetsova, L.V.; Shpak, O.I.; Shatrov, V.A. 1986: Effect of leukocytic interferon on the functional state of bronchoalveolar phagocytes in lung diseases Terapevticheskii Arkhiv 58(4): 83-85
Kuznetsov, V.P. 1989: Current status of the problem of interferon (theoretical and practical aspects) Antibiotiki i Khimioterapiia 34(9): 646-652
Suntsov, S.N.; Ozeretskovskaia, N.N.; Grigorian, S.S.; Shcherbakov, A.M. 1990: The interferon status in helminthiases. 1. Human unilocular hydatid disease Meditsinskaia Parazitologiia i Parazitarnye Bolezni 4: 27-29
Khesin, I.E.; Voronina, F.V.; Marchenko, V.I.; Rusanova, N.A.; Balandin, I.G. 1973: Morphological, cytochemical and biochemical changes in peritoneal macrophages (normal, activated and tolerant) in the process of interferon formation Voprosy Virusologii 18(3): 302-308
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Sel'kova, E.P.; Semenenko, T.A.; Nosik, N.N.; Iudina, T.I.; Amarian, M.P.; Lavrukhina, L.A.; Pantiukhova, T.N.; Tarasova, G.I. 2001: Effect of amyxin--a domestic analog of tilorone--on characteristics of interferon and immune status of man Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 31-35
Priĭmiagi, L.S.; Kremerman, I.B.; Tefanov, V.T.; Tallo, T.G.; Osadchaia, G.S. 1999: Functional status of the interferon system in inapparent and clinical infection with hepatitis B and C viruses Voprosy Virusologii 44(2): 85-88
Seaman, W.E.; Merigan, T.C.; Talal, N. 1979: Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon Journal of Immunology 123(6): 2903-2905
Sarris, A.H.; Talpaz, M.; Deisseroth, A.B.; Estrov, Z. 1996: Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors Leukemia 10(5): 757-765